[1]
|
Mann, S., Frasca, K., Scherrer, S., Henao-Martínez, A.F., Newman, S., Ramanan, P. and Suarez, J.A. (2021) A Review of Leishmaniasis: Current Knowledge and Future Directions. Current Tropical Medicine Reports, 8, 121-132. https://doi.org/10.1007/s40475-021-00232-7
|
[2]
|
CDC (2020) About Leishamiansis. https://cdc.gov/parasites/leishmaniasis/gen_info/faqs.html
|
[3]
|
Knight, C.A., Harris, D.R., Alshammari, S.O., Gugssa, A., Young, T.A. and Lee, C.M. (2023) Leishmaniasis: Recent Epidemiological Studies in the Middle East. Frontiers in Microbiology, 13, Article 1052478. https://doi.org/10.3389/fmicb.2022.1052478
|
[4]
|
Lockard, R.D., Wilson, M.E. and Rodríguez, N.E. (2019) Sex-Related Differences in Immune Response and Symptomatic Manifestations to Infection with Leishmania Species. Journal of Immunology Research, 2019, Article ID: 4103819. https://doi.org/10.1155/2019/4103819
|
[5]
|
Jamal, Q., Shah, A., Rasheed, S.B. and Adnan, M. (2020) In vitro Assessment and Characterization of the Growth and Life Cycle of Leishmania tropica. Pakistan Journal of Zoology, 52, 447-455. https://doi.org/10.17582/journal.pjz/20180718100758
|
[6]
|
Costa-Da-Silva, A.C., Nascimento, D.D.O., Ferreira, J.R., Guimarães-Pinto, K., Freire-De-Lima, L., Morrot, A., Freire-De-Lima, C.G., et al. (2022) Immune Responses in Leishmaniasis: An Overview. Tropical Medicine and Infectious Disease, 7, Article 54. https://doi.org/10.3390/tropicalmed7040054
|
[7]
|
Ollech, A., Solomon, M., Horev, A., Reiss-Huss, S., Dan, B.A., Zvulunov, A., Greenberger, S., et al. (2020) Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients. Acta Dermato-Venereologica, 100, 1-5. https://doi.org/10.2340/00015555-3669
|
[8]
|
Kumari, S., Kumar, V., Tiwari, R.K., Ravidas, V., Pandey, K. and Kumar, A. (2022) Amphotericin B: A Drug of Choice for Visceral Leishmaniasis. Acta Tropica, 235, Article 106661. https://doi.org/10.1016/j.actatropica.2022.106661
|
[9]
|
Roatt, B.M., De Oliveira Cardoso, J.M., De Brito, R.C.F., Coura-Vital, W., De Oliveira Aguiar-Soares, R.D. and Reis, A.B. (2020) Recent Advances and New Strategies on Leishmaniasis Treatment. Applied Microbiology and Biotechnology, 104, 8965-8977. https://doi.org/10.1007/s00253-020-10856-w
|
[10]
|
Shalev-Benami, M., Zhang, Y., Rozenberg, H., Nobe, Y., Taoka, M., Matzov, D., et al. (2017) Atomic Resolution Snapshot of Leishmania ribosome Inhibition by the Aminoglycoside Paromomycin. Nature Communications, 8, Article 1589. https://doi.org/10.1038/s41467-017-01664-4
|
[11]
|
Matos, A.P.S., Viçosa, A.L., Ré, M.I., Ricci-Júnior, E. and Holandino, C. (2020) A Review of Current Treatments Strategies Based on Paromomycin for Leishmaniasis. Journal of Drug Delivery Science and Technology, 57, Article 101664. https://doi.org/10.1016/j.jddst.2020.101664
|
[12]
|
Croft, S.L. and Coombs, G.H. (2003) Leishmaniasis—Current Chemotherapy and Recent Advances in the Search for Novel Drugs. Trends in Parasitology, 19, 502-508. https://doi.org/10.1016/j.pt.2003.09.008
|
[13]
|
Mukherjee, B., Mukherjee, K., Nanda, P., Mukhopadhayay, R., Ravichandiran, V., Bhattacharyya, S.N. and Roy, S. (2021) Probing the Molecular Mechanism of Aggressive Infection by Antimony Resistant Leishmania donovani. Cytokine, 145, Article 155245. https://doi.org/10.1016/j.cyto.2020.155245
|
[14]
|
Yan, C., Lin, Q., Su, B., Su, X., Su, H. and Mo, L. (2022) Analysis and Management of Adverse Drug Reactions after Injection of Amphotericin B in AIDS Patients with Fungal Infection. Natural Science, 14, 62-70. https://doi.org/10.4236/ns.2022.142007
|
[15]
|
Ubals, M., Bosch-Nicolau, P., Sánchez-Montalvá, A., Salvador, F., Aparicio-Español, G., Sulleiro, E., García-Patos, V., et al. (2021) Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B. Pathogens, 10, Article 1253. https://doi.org/10.3390/pathogens10101253
|
[16]
|
Pokharel, P., Ghimire, R. and Lamichhane, P. (2021) Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review. Journal of Tropical Medicine, 2021, Article ID: 8629039. https://doi.org/10.1155/2021/8629039
|
[17]
|
Abdellahi, L., Iraji, F., Mahmoudabadi, A. and Hejazi, S.H. (2022) Vaccination in Leishmaniasis: A Review Article. Iranian Biomedical Journal, 26, 1-35.
|
[18]
|
Kaye, P.M., Mohan, S., Mantel, C., Malhame, M., Revill, P., Le Rutte, E., Malvolti, S., et al. (2021) Overcoming Roadblocks in the Development of Vaccines for Leishmaniasis. Expert Review of Vaccines, 20, 1419-1430. https://doi.org/10.1080/14760584.2021.1990043
|
[19]
|
Orabi, M.A.A., Lahiq, A.A., Awadh, A.A.A., Alshahrani, M.M., Abdel-Wahab, B.A. and Abdel-Sattar, E.S. (2023) Alternative Non-Drug Treatment Options of the Most Neglected Parasitic Disease Cutaneous Leishmaniasis: A Narrative Review. Tropical Medicine and Infectious Disease, 8, Article 275. https://doi.org/10.3390/tropicalmed8050275
|
[20]
|
Reithinger, R., Dujardin, J.C., Louzir, H., Pirmez, C., Alexander, B. and Brooker, S. (2007) Cutaneous Leishmaniasis. The Lancet Infectious Diseases, 7, 581-596. https://doi.org/10.1016/S1473-3099(07)70209-8
|
[21]
|
Kumar, S., Srivastava, A. and Maity, R. (2024) Modeling Climate Change Impacts on Vector-Borne Disease Using Machine Learning Models: Case Study of Visceral leishmaniasis (Kala-Azar) from Indian State of Bihar. Expert Systems with Applications, 237, Article 121490. https://doi.org/10.1016/j.eswa.2023.121490
|
[22]
|
Trájer, A.J. (2021) The Potential Impact of Climate Change on the Seasonality of Phlebotomus neglectus, the Vector of Visceral Leishmaniasis in the East Mediterranean Region. International Journal of Environmental Health Research, 31, 932-950. https://doi.org/10.1080/09603123.2019.1702150
|
[23]
|
Krassner, S.M. (1965) Effect of Temperature on Growth and Nutritional Requirements of Leishmania tarentolae in a Defined Medium. The Journal of Protozoology, 12, 73-78. https://doi.org/10.1111/j.1550-7408.1965.tb01815.x
|
[24]
|
Kattoof, W.M. (2018) Intralesional Streptomycin: New, Safe, and Effective Therapeutic Option for Cutaneous Leishmaniasis. Mustansiriya Medical Journal, 17, 42-46. https://doi.org/10.4103/MJ.MJ_11_18
|
[25]
|
Cole, R.J. and Danielli, J.F. (1963) Nuclear Cytoplasmic Interactions in the Responses of Amoeba proteus and Amoeba discoides to Streptomycin. Experimental Cell Research, 29, 194-206. https://doi.org/10.1016/0014-4827(63)90375-6
|
[26]
|
Maarouf, M., De Kouchkovsky, Y., Brown, S., Petit, P.X. and Robert-Gero, M. (1997) In Vivo Interference of Paromomycin with Mitochondrial Activity of Leishmania. Experimental Cell Research, 232, 339-348. https://doi.org/10.1006/excr.1997.3500
|
[27]
|
Horváth, A., Neboháčová, M., Lukeš, J. and Maslov, D.A. (2002) Unusual Polypeptide Synthesis in the Kinetoplast-Mitochondria from Leishmania tarentolae. Identification of Individual de novo Translation Products. Journal of Biological Chemistry, 277, 7222-7230. https://doi.org/10.1074/jbc.M109715200
|
[28]
|
Hobbie, S.N., Kaiser, M., Schmidt, S., Shcherbakov, D., Janusic, T., Brun, R. and Böttger, E.C. (2011) Genetic Reconstruction of Protozoan rRNA Decoding Sites Provides a Rationale for Paromomycin Activity against Leishmania and Trypanosoma. PLOS Neglected Tropical Diseases, 5, e1161. https://doi.org/10.1371/journal.pntd.0001161
|
[29]
|
National Center for Biotechnology Information (2024) PubChem Compound Summary for CID 19649, Streptomycin. https://pubchem.ncbi.nlm.nih.gov/compound/Streptomycin-a
|
[30]
|
National Center for Biotechnology Information (2024) PubChem Compound Summary for CID 5280965, Amphotericin B. https://pubchem.ncbi.nlm.nih.gov/compound/Amphotericin-b
|
[31]
|
Chattopadhyay, A. and Jafurulla, M. (2011) A Novel Mechanism for an Old Drug: Amphotericin B in the Treatment of Visceral Leishmaniasis. Biochemical and Biophysical Research Communications, 416, 7-12. https://doi.org/10.1016/j.bbrc.2011.11.023
|
[32]
|
Hartsel, S. and Bolard, J. (1996) Amphotericin B: New Life for an Old Drug. Trends in Pharmacological Sciences, 17, 445-449. https://doi.org/10.1016/S0165-6147(96)01012-7
|
[33]
|
Gundampati, R.K., Chandrasekaran, S. and Jagannadham, M.V. (2013) Molecular Docking Study on the Interaction between Trypanothione Reductase and Mangiferin for Antileishmanial Activity. Bangladesh Journal of Pharmacology, 8, 40-43. https://doi.org/10.3329/bjp.v8i1.13034
|
[34]
|
Shaukat, A., Mirza, H.M., Ansari, A.H., Yasinzai, M., Zaidi, S.Z., Dilshad, S. and Ansari, F.L. (2013) Benzimidazole Derivatives: Synthesis, Leishmanicidal Effectiveness, and Molecular Docking Studies. Medicinal Chemistry Research, 22, 3606-3620. https://doi.org/10.1007/s00044-012-0375-5
|
[35]
|
Querido, J.B., Mancera-Martínez, E., Vicens, Q., Bochler, A., Chicher, J., Simonetti, A. and Hashem, Y. (2017) The Cryo-EM Structure of a Novel 40S Kinetoplastid-Specific Ribosomal Protein. Structure, 25, 1785-1794. https://doi.org/10.1016/j.str.2017.09.014
|
[36]
|
Chemical Computing Group ULC (2019) Molecular Operating Environment (MOE). Montreal.
|
[37]
|
Shulman, E., Belakhov, V., Wei, G., Kendall, A., Meyron-Holtz, E.G., Ben-Shachar, D., Schacht, T. and Baasov, T. (2014) Designer Aminoglycosides that Selectively Inhibit Cytoplasmic Rather than Mitochondrial Ribosomes Show Decreased Ototoxicity a Strategy for the Treatment of Genetic Diseases. Journal of Biological Chemistry, 289, 2318-2330. https://doi.org/10.1074/jbc.M113.533588
|
[38]
|
Shalev-Benami, M., Zhang, Y., Matzov, D., Halfon, Y., Zackay, A., Rozenberg, H., Skiniotis, G., et al. (2016) 2.8-Å Cryo-EM Structure of the Large Ribosomal Subunit from the Eukaryotic Parasite Leishmania. Cell Reports, 16, 288-294. https://doi.org/10.1016/j.celrep.2016.06.014
|
[39]
|
Bagnéris, C., DeCaen, P.G., Naylor, C.E., Pryde, D.C., Nobeli, I., Clapham, D.E. and Wallace, B.A. (2014) Prokaryotic NavMs Channel as a Structural and Functional Model for Eukaryotic Sodium Channel Antagonism. Proceedings of the National Academy of Sciences, 111, 8428-8433. https://doi.org/10.1073/pnas.1406855111
|
[40]
|
Fang, Y., Kirkland, J., Amaye, I.J., Jackson-Ayotunde, P. and George Jr., M. (2019) Molecular Docking Studies on Anticonvulsant Enaminones Inhibiting Voltage-Gated Sodium Channels. Open Journal of Physical Chemistry, 9, 241-257. https://doi.org/10.4236/ojpc.2019.94015
|
[41]
|
Batt, C.A. and Tortorello, M.L. (2023) Encyclopedia of Food Microbiology. 2nd Edition, Academic Press Elsevier, Cambridge, MA. http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=542944
|
[42]
|
Trevor, A.J., Katzung, B.G., Masters, S.B. and Kruidering-Hall, M. (2010) Pharmacology Examination & Board Review. McGraw-Hill Medical, New York, 121-132
|
[43]
|
Wasan, E., Mandava, T., Crespo-Moran, P., Nagy, A. and Wasan, K.M. (2022) Review of Novel Oral Amphotericin B Formulations for the Treatment of Parasitic Infections. Pharmaceutics, 14, Article 2316. https://doi.org/10.3390/pharmaceutics14112316
|
[44]
|
Berman, J. (2015) Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis. The American Journal of Tropical Medicine and Hygiene, 92, 471-473. https://doi.org/10.4269/ajtmh.14-0743
|
[45]
|
Parvez, S., Yadagiri, G., Gedda, M.R., Singh, A., Singh, O.P., Verma, A., Sundar, A. and Mudavath, S.L. (2020) Modified Solid Lipid Nanoparticles Encapsulated with Amphotericin B and Paromomycin: An Effective Oral Combination Against Experimental Murine Visceral Leishmaniasis. Scientific Reports, 10, Article No. 12243. https://doi.org/10.1038/s41598-020-69276-5
|
[46]
|
Esfandiari, F., Motazedian, M.H., Asgari, Q., Morowvat, M.H., Molaei, M. and Heli, H. (2019) Paromomycin-Loaded Mannosylated Chitosan Nanoparticles: Synthesis, Characterization and Targeted Drug Delivery against Leishmaniasis. Acta Tropica, 197, Article 105072. https://doi.org/10.1016/j.actatropica.2019.105072
|